APP and early-onset autosomal dominant Alzheimer disease: Nonetheless, we are confident that our results are reproducible also in humans basing on similar data recently collected in a model of Alzheimer’s disease (AD), showing that tDCS promotes the degradation and clearance of oligomeric β-amyloid (Aβ42), thus improving spatial learning and memory in APP/PS1 transgenic mice31.